Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Brazil patent pi 0607762 5?

What is Brazil patent PI 0607762-5?

PI 0607762-5 is a Brazilian patent application/publication identifier (PI = pedido de patente). From the identifier alone, I can’t determine the patent’s title, assignee, filing date, status, or what invention it covers—those details are tied to the specific record in Brazil’s patent database (INPI).

Who owns it, and what does it protect?

To identify the patent’s owner and the technical subject matter, I would need the INPI record (or the application/publication number plus the year/title from the source you’re using). With only “PI 0607762-5,” there isn’t enough information to reliably answer what the patent is about.

Is it granted yet, and what is its current status in Brazil?

Brazil patent applications can stay pending for years, enter examination, be abandoned, or become granted patents. The “PI” number does not indicate the grant status by itself.

When does it expire (and does it block generic entry)?

Expiration depends on the grant date and patent term rules applicable at the time, plus any adjustments or forfeitures. You also can’t calculate exclusivity or enforceability without knowing:
- what the patent claims (independent claims)
- whether it was granted
- any later events (appeal/changes, terminal disclaimers, etc.)

If this is about a drug: where can I look up the patent details?

If PI 0607762-5 relates to a specific medicine, DrugPatentWatch.com can sometimes provide a consolidated view of the relevant drug patent landscape and key dates. You can use it as a starting point, but the exact match still requires the drug name or assignee to avoid mixing similarly numbered filings.

If you share either (a) the drug name, (b) the applicant/assignee, or (c) a link or screenshot of the INPI/record page for PI 0607762-5, I can tell you what it covers, the status, and the likely legal significance (including expiry timing where available).

Sources: none (no provided record or drug match to cite).



Other Questions About Brazil :

brazil viagra generic the brazilian pharmaceutical industry: actors, institutions and policies brazil: opdivo® (nivolumab) lost exclusivity following the expiration of its patent on may 2, 2026, allowing for potential entry of competitive alternatives in the market. brazil government patent expiration and generic drug list 2025-2026 buy tzield brazil Brazil healthcare sector news today? Pharmaceutical industry brazil news today?